Neuravi

🗓 Founded 2009👥 3 employees💰 Last funded 2015
Medical Equipment Manufacturing🌐 neuravi.com
Website LinkedIn
Neuravi is dedicated to improving clinical outcomes for stroke patients. The company’s stroke therapy platform, the EmboTrap®II Revascularization Device, is CE marked and commercially available in Europe. The device has been available for investigational use only in the United States. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke. In April 2017, Codman Neuro announced the acquisition of Neuravi, which is now part of the Johnson and Johnson family of medical device companies. Neuravi was founded in 2009 and is headquartered in Galway, Ireland.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Neuravi?
Neuravi has 1 investors on record on gritt.io and 1 late-stage investors.
When did Neuravi last raise funding?
The most recent investment in Neuravi recorded on gritt.io was in 2015.
When was Neuravi founded?
Neuravi was founded in 2009.
What industry is Neuravi in?
Neuravi operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.